Literature DB >> 2241505

The hippocampus and parahippocampus in schizophrenia, suicide, and control brains.

L L Altshuler1, M F Casanova, T E Goldberg, J E Kleinman.   

Abstract

Recent postmortem studies in schizophrenia have shown abnormalities in medial temporal lobe structures, including the hippocampus and parahippocampus. We tried to replicate previous studies and to explore the specificity of this finding to schizophrenia. The anterior hippocampus and parahippocampal cortex were evaluated for area and shape in postmortem tissue from 12 schizophrenic, 17 nonschizophrenic suicide, and 10 nonpsychiatric control brains. No significant differences were found in hippocampal area, but the parahippocampal cortex was significantly smaller in the schizophrenic group than in the control group. When parahippocampi from right and left sides were analyzed separately, both the suicide and schizophrenic groups had smaller parahippocampi on the right side than did the controls [corrected]. The suicide group exhibited greater parahippocampal areas in the left than in the right tissue samples within the group, while such a difference did not exist in the schizophrenic or control groups. This study demonstrated changes in temporal lobe structures in both schizophrenic and nonschizophrenic suicide groups.

Entities:  

Mesh:

Year:  1990        PMID: 2241505     DOI: 10.1001/archpsyc.1990.01810230045008

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  34 in total

1.  Hippocampal pyramidal cell disarray correlates negatively to cell number: implications for the pathogenesis of schizophrenia.

Authors:  S A Jönsson; A Luts; N Guldberg-Kjaer; A Brun
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

2.  Disappearance of hypothalamic TRH asymmetry in suicide patients.

Authors:  D Jordan; F Borson-Chazot; M Veisseire; S Deluermoz; D Malicier; J Dalery; N Kopp
Journal:  J Neural Transm Gen Sect       Date:  1992

3.  Identifying global anatomical differences: deformation-based morphometry.

Authors:  J Ashburner; C Hutton; R Frackowiak; I Johnsrude; C Price; K Friston
Journal:  Hum Brain Mapp       Date:  1998       Impact factor: 5.038

Review 4.  Toward a biosignature for suicide.

Authors:  Maria A Oquendo; Gregory M Sullivan; Katherin Sudol; Enrique Baca-Garcia; Barbara H Stanley; M Elizabeth Sublette; J John Mann
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

5.  A quantitative magnetic resonance imaging study of patients with schizophrenia.

Authors:  Y Kawasaki; Y Maeda; K Urata; M Higashima; N Yamaguchi; M Suzuki; T Takashima; Y Ide
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

6.  Progressive deformation of deep brain nuclei and hippocampal-amygdala formation in schizophrenia.

Authors:  Lei Wang; Daniel Mamah; Michael P Harms; Meghana Karnik; Joseph L Price; Mokhtar H Gado; Paul A Thompson; Deanna M Barch; Michael I Miller; John G Csernansky
Journal:  Biol Psychiatry       Date:  2008-09-23       Impact factor: 13.382

7.  Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients.

Authors:  Ameer Y Taha; Yewon Cheon; Kaizong Ma; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Psychiatr Res       Date:  2013-02-18       Impact factor: 4.791

8.  Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression.

Authors:  Adolfo Sequeira; Firoza Mamdani; Carl Ernst; Marquis P Vawter; William E Bunney; Veronique Lebel; Sonia Rehal; Tim Klempan; Alain Gratton; Chawki Benkelfat; Guy A Rouleau; Naguib Mechawar; Gustavo Turecki
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

9.  Viral antibodies in blood in obsessive compulsive disorder.

Authors:  S Khanna; V Ravi; P K Shenoy; A Chandramukhi; S M Channabasavanna
Journal:  Indian J Psychiatry       Date:  1997-07       Impact factor: 1.759

10.  Brain-derived neurotrophic factor: role in depression and suicide.

Authors:  Yogesh Dwivedi
Journal:  Neuropsychiatr Dis Treat       Date:  2009-08-20       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.